BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35177899)

  • 1. Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
    Tseng CH
    Int J Chron Obstruct Pulmon Dis; 2022; 17():285-295. PubMed ID: 35177899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
    Tseng CH
    BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and risk of chronic obstructive pulmonary disease in diabetes patients.
    Tseng CH
    Diabetes Metab; 2019 Apr; 45(2):184-190. PubMed ID: 29804817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
    [No Abstract]   [Full Text] [Related]  

  • 5. Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis.
    Tseng CH
    J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30262775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin reduces risk of varicose veins in patients with type 2 diabetes.
    Tseng CH
    Diabetes Metab Res Rev; 2020 Feb; 36(2):e3206. PubMed ID: 31322821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
    Tseng CH
    J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone.
    Tseng CH
    Aging Dis; 2020 May; 11(3):658-667. PubMed ID: 32489710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus.
    Tseng CH
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29954747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.
    Tseng CH
    Front Endocrinol (Lausanne); 2022; 13():1036885. PubMed ID: 36277720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Tseng CH
    Eur J Endocrinol; 2019 Jun; 180(6):365-372. PubMed ID: 30986765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease.
    Yen FS; Wei JC; Yang YC; Hsu CC; Hwu CM
    Sci Rep; 2020 Jun; 10(1):10298. PubMed ID: 32581289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.